Company: ICUI
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0000883984-25-000030
Chunk: 125

Company: ICU MEDICAL INC/DE
Filing Date: 2025-08-07
Form: 10-Q
Item: Item 8
Chunk 125
---
Net Income (Loss) Per Share

 Basic net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted income (loss) per share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period plus dilutive securities. Dilutive securities include outstanding common stock options and unvested restricted stock units, less the number of shares that could have been purchased with the proceeds from the exercise of the options, using the treasury stock method. Options and restricted stock units that are anti-dilutive are not included in the treasury stock method calculation. A net loss for the three and six months ended June 30, 2024 causes all of the potentially dilutive common shares to be antidilutive and, accordingly, they were not included in the computation of diluted earnings per share, and basic and diluted net loss per share are equal for each of these periods.    The following table presents the calculation of net earnings per common share (“EPS”) — basic and diluted (in thousands, except per share data):  

19

ICU MEDICAL, INC. AND SUBSIDIARIESNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Continued)

 Three months ended June 30,Six months ended June 30, 2025202420252024Net income (loss)$35,338 $(21,406)$19,862 $(60,877)Weighted-average number of common shares outstanding (basic)24,645 24,393 24,593 24,295 Dilutive securities(1)63 — 153 — Weighted-average common and common equivalent shares outstanding (diluted)24,708 24,393 24,746 24,295 EPS — basic$1.43 $(0.88)0.81$(2.51)EPS — diluted$1.43 $(0.88)0.80$(2.51)Total anti-dilutive stock options and restricted stock awards65 21640 202 _______________________________(1)    Due to the net loss for the three and six months ended June 30, 2024, there are no potentially dilutive common shares included in the computation of diluted earnings per share.

Note 9:    Derivatives and Hedging Activities

Hedge Accounting and Hedging Program